North America shall retain its dominance in the Atopic Dermatitis Drugs Market with a CAGR of 27% during the forecast period 2020-2027
Research and development in manufacturing novel drugs, rising demand for biologics and product approvals are other factors augmenting market growth. On this premise, the atopic dermatitis market is poised to surpass a valuation of US$ 19 Bn by the end of the forecast period.
Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4603
Key Takeaways of Global Atopic Dermatitis Drugs Market Study
• Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
• PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.
• Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.
• North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
• Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities.
For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603
“The global atopic dermatitis drugs market demonstrates exceptional potential in the future. Increasing incidence of dermatological disorders, combined with intensive research and development in novel pipeline drugs, is expected to propel market share,” concludes a Fact.MR analyst
Development of Novel Drugs to Determine Market Competitiveness
Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.
Looking for more information?
The research study on the global atopic dermatitis market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global atopic dermatitis market over 2020-2027. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2027. Market statistics have been presented on the basis of Drug Class (Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants and Others.) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) across five major regions.
Get Full Access of the Report @ https://www.factmr.com/checkout/4603/S
Fact. MR’s Domain Knowledge in Healthcare
Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.
Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Website : https://www.factmr.com
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America shall retain its dominance in the Atopic Dermatitis Drugs Market with a CAGR of 27% during the forecast period 2020-2027 here
News-ID: 2233960 • Views: 277
More Releases from Fact.MR
Autonomous Last Mile Delivery Market to Show Commendable Growth at a CAGR of 19% …
It is anticipated that the global autonomous last-mile delivery market would expand at a CAGR of over 19%. The need for autonomous last-mile delivery has rapidly increased in recent years. Due to advancements in delivery system technology, the market has experienced tremendous growth in recent years. The market's growth can be attributed to the rising use of autonomous vehicles for human-free delivery of commodities. Additionally, the expansion of the e-Commerce industry
Point of Care Diagnostics Market is Prophesied to Reach US$ 66 Billion by the en …
According to this new report, point of care test (POCT) kit shipments are anticipated to soar at a CAGR of almost 7% between 2021 and 2028. The global point of care diagnostics market had a value of $34.1 billion in 2020 and is projected to grow to $66 billion by the end of 2028. In the upcoming years, point of care diagnostics will generate more money due to the rising global
Global Calcium Fluoride Market is Predicted to Reach a Valuation of US$ 3.5 Bill …
From 2023 to 2033, there will be a sharp rise in the demand for calcium fluoride, with a CAGR of 8.1% predicted. Calcium fluoride is a crucial component in the production of calcium sulfate and hydrogen fluoride. According to data given by Fact.MR, a supplier of market research and competitive intelligence, the global calcium fluoride market is anticipated to reach a value of US$ 3.5 billion by the end of
Brine Chillers Market is Predicted to Rise at a CAGR of 4.4% Through 2033
Brine chillers are used to provide cooling solutions in a variety of industries. Including chemical processing, pharmaceuticals, food and beverage production, and HVAC systems, among others. The global brine chillers market is anticipated to reach a value of US$ 11.76 billion in 2023 and increase at a CAGR of 4.4% between 2023 and 2033. The brine chillers industry is likely to be worth US$ 18.09 billion by 2033.In the upcoming years,
More Releases for Atopic
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”. In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to
Current research: Demand for Atopic Dermatitis Treatment Market rapidly growing …
Report Ocean released a report deciphering the Atopic Dermatitis Treatment Market report that provides in-depth analysis and crucial insights into key factors that are crucial to the success of the market. The report is a systematic study of the market that provides key statistics on trends, analyst views, competitive landscapes, and key regions markets report is a comprehensive study. In this research report, key business trends and upcoming Atopic Dermatitis Treatment
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - ResearchByMarkets …
"Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018", provides an overview of the Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from
Atopic Dermatitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atopic Dermatitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Pipeline Review, H2 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored
Global Atopic Dermatitis (Atopic Eczema) Treatment Market: Market Estimation, Dy …
Atopic dermatitis is also known as atopic eczema. Atopic dermatitis is a type of inflammatory disease which is of unknown origin usually starts in early infancy, but also affects a major number of adults. Atopic dermatitis results in itchy, red, swollen and cracked skin. Many people with atopic dermatitis may develop hay fever and asthma. The causes are unknown but it is found to involve inherited, immune system dysfunction, environmental